Stay updated on ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:44:47.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3; no other page content or layout changes are visible.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:15.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed a government funding/operating status notice. These edits are administrative and do not affect study details or eligibility.
    Difference
    0.4%
    Check dated 2026-02-11T15:09:26.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:44:34.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The update adds a 'Show glossary' option and updates metadata labels (Last Update Submitted that Met QC Criteria, Revision: v3.4.0, No FEAR Act Data), while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:35:03.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4 with no substantive changes to the study content, eligibility criteria, or listed locations.
    Difference
    0.1%
    Check dated 2026-01-14T03:23:12.000Z thumbnail image

Stay in the know with updates to ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.